BetterLife Pharma Inc. SEC filings BETRF

BetterLife Pharma Inc. has 244 filings in SEC EDGAR's recent list, going back to Aug 7, 2009. Its latest annual report, Form 20-F, was filed on Jun 1, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 17, 2019, covering the quarter ended Apr 30, 2019. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on January 31.

BetterLife Pharma Inc. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 30, 2026 Sep 29, 2026
6-K Current report (foreign issuer) Sep 15, 2026 Sep 14, 2026
6-K Current report (foreign issuer) Sep 11, 2026 Sep 11, 2026
6-K Current report (foreign issuer) Aug 24, 2026 Aug 24, 2026
6-K Current report (foreign issuer) Aug 5, 2026 Aug 3, 2026
6-K Current report (foreign issuer) Jun 26, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Jun 25, 2026 Jun 25, 2026
20-F Annual report (foreign issuer) Jun 1, 2026 Jan 31, 2026
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
6-K Current report (foreign issuer) Sep 29, 2025 Sep 26, 2025
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
6-K Current report (foreign issuer) Jun 27, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Jun 23, 2025 Jun 23, 2025
20-F Annual report (foreign issuer) Jun 2, 2025 Jan 31, 2025
6-K Current report (foreign issuer) May 30, 2025 May 29, 2025
6-K Current report (foreign issuer) May 7, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
6-K Current report (foreign issuer) Dec 31, 2024 Oct 31, 2024
6-K Current report (foreign issuer) Dec 9, 2024 Dec 9, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Sep 26, 2024 Jul 31, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 29, 2024
6-K Current report (foreign issuer) Aug 8, 2024 Aug 7, 2024
6-K Current report (foreign issuer) Jul 15, 2024 Jul 15, 2024
6-K Current report (foreign issuer) Jun 28, 2024 Apr 30, 2024
6-K Current report (foreign issuer) Jun 17, 2024 Jun 17, 2024
20-F Annual report (foreign issuer) May 30, 2024 Jan 31, 2024
6-K Current report (foreign issuer) May 14, 2024 May 24, 2024
6-K Current report (foreign issuer) May 6, 2024 May 3, 2024
6-K Current report (foreign issuer) Apr 11, 2024 Apr 11, 2024
6-K Current report (foreign issuer) Apr 4, 2024 Apr 4, 2024
6-K Current report (foreign issuer) Mar 5, 2024 Mar 5, 2024
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
6-K Current report (foreign issuer) Dec 29, 2023 Oct 31, 2023
6-K Current report (foreign issuer) Dec 18, 2023 Dec 18, 2023
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
6-K Current report (foreign issuer) Sep 29, 2023 Sep 29, 2023
6-K Current report (foreign issuer) Sep 28, 2023 Jul 31, 2023
6-K Current report (foreign issuer) Sep 5, 2023 Sep 5, 2023
6-K Current report (foreign issuer) Jul 13, 2023 Jul 13, 2023
6-K Current report (foreign issuer) Jun 28, 2023 Jun 27, 2023
6-K Current report (foreign issuer) Jun 28, 2023 Apr 30, 2023
6-K Current report (foreign issuer) Jun 9, 2023 Jun 9, 2023
20-F/A Amended annual report (foreign issuer) Jun 6, 2023 Jan 31, 2023
20-F Annual report (foreign issuer) May 31, 2023 Jan 31, 2023
6-K Current report (foreign issuer) May 10, 2023 May 10, 2023
6-K Current report (foreign issuer) Apr 25, 2023 Apr 25, 2023
6-K Current report (foreign issuer) Mar 14, 2023 Mar 14, 2023
6-K Current report (foreign issuer) Mar 8, 2023 Mar 8, 2023
6-K Current report (foreign issuer) Mar 7, 2023 Mar 7, 2023
6-K Current report (foreign issuer) Feb 28, 2023 Feb 28, 2023
6-K Current report (foreign issuer) Jan 18, 2023 Jan 17, 2023
6-K Current report (foreign issuer) Dec 23, 2022 Oct 31, 2022
6-K Current report (foreign issuer) Dec 8, 2022 Dec 7, 2022
6-K Current report (foreign issuer) Nov 8, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Sep 27, 2022 Jul 31, 2022
6-K Current report (foreign issuer) Jul 12, 2022 Jul 12, 2022
6-K Current report (foreign issuer) Jun 29, 2022 Apr 30, 2022
20-F Annual report (foreign issuer) Jun 6, 2022 Jan 31, 2022
NT 20-F Filing Jun 1, 2022 Jan 31, 2022
6-K Current report (foreign issuer) Apr 6, 2022 Apr 6, 2022
6-K Current report (foreign issuer) Mar 4, 2022 Mar 4, 2022
6-K Current report (foreign issuer) Jan 20, 2022 Jan 20, 2022
6-K Current report (foreign issuer) Dec 23, 2021 Dec 23, 2021
6-K Current report (foreign issuer) Dec 16, 2021 Oct 31, 2021
6-K Current report (foreign issuer) Dec 15, 2021 Dec 15, 2021
6-K Current report (foreign issuer) Dec 9, 2021 Dec 9, 2021
6-K Current report (foreign issuer) Nov 23, 2021 Nov 23, 2021
6-K Current report (foreign issuer) Nov 16, 2021 Nov 16, 2021
6-K Current report (foreign issuer) Oct 20, 2021 Oct 20, 2021
6-K Current report (foreign issuer) Sep 29, 2021 Sep 29, 2021
6-K Current report (foreign issuer) Sep 24, 2021 Jul 31, 2021
6-K Current report (foreign issuer) Sep 21, 2021 Sep 20, 2021
6-K Current report (foreign issuer) Aug 3, 2021 Aug 3, 2021
6-K Current report (foreign issuer) Jul 16, 2021 Jul 16, 2021
6-K Current report (foreign issuer) Jun 29, 2021 Jun 28, 2021
6-K Current report (foreign issuer) Jun 25, 2021 Jun 25, 2021
20-F/A Amended annual report (foreign issuer) Jun 23, 2021 Jan 31, 2021
20-F/A Amended annual report (foreign issuer) Jun 8, 2021 Jan 31, 2021
6-K Current report (foreign issuer) Jun 7, 2021 Jun 7, 2021
6-K Current report (foreign issuer) Jun 7, 2021 May 31, 2021
20-F Annual report (foreign issuer) Jun 1, 2021 Jan 31, 2021
6-K Current report (foreign issuer) May 28, 2021 May 28, 2021
6-K Current report (foreign issuer) May 21, 2021 May 20, 2021
6-K Current report (foreign issuer) May 17, 2021 May 14, 2021
6-K Current report (foreign issuer) May 5, 2021 May 4, 2021
6-K Current report (foreign issuer) Apr 27, 2021 Oct 31, 2020
6-K Current report (foreign issuer) Apr 20, 2021 Apr 20, 2021
6-K Current report (foreign issuer) Apr 1, 2021 Mar 31, 2021
6-K Current report (foreign issuer) Mar 16, 2021 Mar 16, 2021
6-K Current report (foreign issuer) Mar 15, 2021 Mar 15, 2021
6-K Current report (foreign issuer) Mar 8, 2021 Mar 8, 2021
6-K Current report (foreign issuer) Feb 2, 2021 Feb 2, 2021
6-K Current report (foreign issuer) Jan 19, 2021 Jan 19, 2021
6-K Current report (foreign issuer) Dec 31, 2020 Oct 31, 2020
6-K Current report (foreign issuer) Dec 29, 2020 Dec 29, 2020
6-K Current report (foreign issuer) Dec 22, 2020 Dec 21, 2020
6-K Current report (foreign issuer) Dec 8, 2020 Dec 8, 2020
6-K Current report (foreign issuer) Dec 2, 2020 Dec 2, 2020
6-K Current report (foreign issuer) Nov 23, 2020 Nov 23, 2020
6-K Current report (foreign issuer) Oct 20, 2020 Oct 19, 2020
6-K Current report (foreign issuer) Oct 9, 2020 Oct 8, 2020
6-K Current report (foreign issuer) Sep 29, 2020 Jul 31, 2020
6-K Current report (foreign issuer) Sep 9, 2020 Sep 9, 2020
6-K/A Form 6-k/a Aug 18, 2020 Apr 30, 2020
6-K Current report (foreign issuer) Aug 11, 2020 Aug 11, 2020
6-K Current report (foreign issuer) Jul 31, 2020 Jul 30, 2020
6-K Current report (foreign issuer) Jun 29, 2020 Apr 30, 2020
6-K Current report (foreign issuer) Jun 29, 2020 Jun 29, 2020
6-K Current report (foreign issuer) Jun 15, 2020 Jun 15, 2020
6-K Current report (foreign issuer) Jun 9, 2020 Jun 9, 2020
20-F/A Amended annual report (foreign issuer) Jun 5, 2020 Jan 31, 2020
20-F Annual report (foreign issuer) Jun 1, 2020 Jan 31, 2020
NT 20-F Filing Jun 1, 2020 Jan 31, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
6-K Current report (foreign issuer) May 13, 2020 May 13, 2020
6-K Current report (foreign issuer) Apr 8, 2020 Apr 7, 2020
6-K Current report (foreign issuer) Jan 23, 2020 Jan 22, 2020
6-K Current report (foreign issuer) Jan 6, 2020 Jan 6, 2020
6-K Current report (foreign issuer) Dec 26, 2019 Oct 31, 2019
6-K Current report (foreign issuer) Dec 5, 2019 Dec 5, 2019
6-K Current report (foreign issuer) Dec 3, 2019 Dec 3, 2019
6-K Current report (foreign issuer) Oct 8, 2019 Oct 8, 2019
6-K Current report (foreign issuer) Oct 1, 2019 Sep 30, 2019
6-K Current report (foreign issuer) Sep 9, 2019 Sep 6, 2019
10-Q Quarterly report Jun 17, 2019 Apr 30, 2019
NT 10-Q Filing Jun 17, 2019 Apr 30, 2019
8-K Current report
Unregistered share sale
May 21, 2019 May 21, 2019
10-K Annual report May 3, 2019 Jan 31, 2019
NT 10-K Filing Apr 30, 2019 Jan 31, 2019
DEF 14A Proxy statement Feb 19, 2019 Feb 15, 2019
8-K Current report
Unregistered share sale, Auditor change
Feb 4, 2019 Jan 29, 2019
8-K Current report
Material agreement
Dec 19, 2018 Dec 19, 2018
10-Q Quarterly report Dec 18, 2018 Oct 31, 2018
NT 10-Q Filing Dec 18, 2018 Oct 31, 2018
8-K Current report
Unregistered share sale
Nov 6, 2018 Nov 6, 2018
8-K Current report
Unregistered share sale, Officer or director change
Sep 18, 2018 Sep 18, 2018
10-Q Quarterly report Sep 14, 2018 Jul 31, 2018
10-Q Quarterly report Jun 19, 2018 Apr 30, 2018
NT 10-Q Filing Jun 15, 2018 Apr 30, 2018
8-K/A Amended current report
Acquisition or sale of assets, Unregistered share sale
May 16, 2018 May 16, 2018
10-K Annual report May 1, 2018 Jan 31, 2018
8-K Current report
Acquisition or sale of assets, Unregistered share sale
Mar 12, 2018 Mar 12, 2018
8-K Current report
Unregistered share sale
Dec 19, 2017 Dec 19, 2017
10-Q Quarterly report Dec 15, 2017 Oct 31, 2017
DEF 14A Proxy statement Oct 27, 2017 Oct 24, 2017
10-Q Quarterly report Sep 15, 2017 Jul 31, 2017
NT 10-Q Filing Sep 15, 2017 Jul 31, 2017
8-K Current report
Material agreement, Officer or director change
Sep 13, 2017 Sep 12, 2017
10-Q Quarterly report Jun 13, 2017 Apr 30, 2017
10-K Annual report Apr 28, 2017 Jan 31, 2017
10-Q Quarterly report Dec 12, 2016 Oct 31, 2016
DEF 14A Proxy statement Nov 28, 2016 Nov 28, 2016
10-Q Quarterly report Sep 12, 2016 Jul 31, 2016
10-Q Quarterly report Jun 14, 2016 Apr 30, 2016
10-K/A Amended annual report Jun 7, 2016 Jan 31, 2016
10-K Annual report Apr 29, 2016 Jan 31, 2016
8-K/A Amended current report
Acquisition or sale of assets, Unregistered share sale
Feb 3, 2016 Feb 3, 2016
10-Q Quarterly report Dec 15, 2015 Oct 31, 2015
D Filing Dec 8, 2015 —
DEF 14A Proxy statement Nov 25, 2015 Dec 30, 2015
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Nov 23, 2015 Nov 23, 2015
8-K Current report
Officer or director change
Nov 18, 2015 Nov 18, 2015
8-K Current report
Material agreement
Nov 17, 2015 Nov 17, 2015
10-Q Quarterly report Sep 10, 2015 Jul 31, 2015
8-K Current report
Unregistered share sale
Jul 30, 2015 Jul 24, 2015
10-Q Quarterly report Jun 17, 2015 Apr 30, 2015
10-K/A Amended annual report Jun 17, 2015 Jan 31, 2015
NT 10-Q Filing Jun 16, 2015 Apr 30, 2015
10-K Annual report May 15, 2015 Jan 31, 2015
NT 10-K Filing May 4, 2015 Jan 31, 2015
8-K Current report
Bylaw or fiscal year change, Other events
Apr 17, 2015 Apr 7, 2015
8-K Current report
Material agreement, Unregistered share sale
Mar 26, 2015 Mar 19, 2015
8-K Current report
Officer or director change
Feb 10, 2015 Feb 5, 2015
10-Q Quarterly report Dec 15, 2014 Oct 31, 2014
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Oct 9, 2014 Sep 26, 2014
10-Q Quarterly report Sep 15, 2014 Jul 31, 2014
DEFR14A Schedule 14a Aug 27, 2014 —
UPLOAD Letter from the SEC Aug 25, 2014 —
DEFR14A Schedule 14a Aug 20, 2014 —
UPLOAD Letter from the SEC Aug 15, 2014 —
PRE 14A Preliminary proxy statement Aug 8, 2014 Aug 8, 2014
8-K Current report
Officer or director change
Jul 28, 2014 Jul 24, 2014
10-Q Quarterly report Jun 16, 2014 Apr 30, 2014
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2014 Jun 3, 2014
10-K Annual report May 16, 2014 Jan 31, 2014
NT 10-K Form 10-k May 2, 2014 Jan 31, 2014
DEF 14A Proxy statement Apr 30, 2014 Apr 28, 2014
UPLOAD Letter from the SEC Apr 10, 2014 —
CORRESP Letter to the SEC Apr 9, 2014 —
UPLOAD Letter from the SEC Apr 8, 2014 —
PRE 14A Preliminary proxy statement Apr 1, 2014 Apr 1, 2014
8-K Current report
Auditor change
Mar 18, 2014 Mar 5, 2014
10-Q Quarterly report Dec 16, 2013 Oct 31, 2013
10-Q Quarterly report Sep 16, 2013 Jul 31, 2013
10-Q Quarterly report Jun 19, 2013 Apr 30, 2013
NT 10-Q Form 12b-25 Jun 14, 2013 Apr 30, 2013
10-K Annual report May 16, 2013 Jan 31, 2013
NT 10-K Filing May 2, 2013 Jan 31, 2013
10-Q Quarterly report Dec 14, 2012 Oct 31, 2012

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BETRF (OTC)
Fiscal year ends
January 31
Incorporated in
British Columbia, Canada
Headquarters
Vancouver, British Columbia, Canada
SEC filer status
Non-accelerated filer
SEC CIK
1464165
Former names
Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.